Buy or sell Biofourmis stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
About Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
Investors
Funding History
| December 2015 | $100K |
|---|---|
| August 2016 | $1.0M |
| May 2017 | $500K |
| December 2017 | $5.0M |
| May 2018 | $2.0M |
| May 2019 | $35.0M |
| September 2020 | $100M |
Management
Founder & CEO
Kuldeep Singh Rajput
CO-Founder & MD
Wendou Niu
Chief Product Officer
Sylvain Goblet
CTO
Milan Shah
COO
Jaydev Thakkar
Board Member
Anvesh Ramineni
VP, Data Science
Nandakumar Selvaraj
VP Of Software Development
Siddalingamurthy BG
Board Observer
Ryan Collins
VP, Human Resources
Andy Zucker
Chief Technology Officer
Milan Shah
Board member and Medical Advisor
Maulik Majmudar
VP Operations
Trace Brookins
Press
TechCrunch - Sep, 3 2020
TechCrunch - May, 21 2019
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
